Case Study: a large pharmaceutical company improves dermatology patient experience insights with Evidation

Measuring quality of life and patient experience with longitudinal digital measures

A dermatology brand at a large pharmaceutical company needed to better understand the drivers and barriers to treatment initiation for a skin condition. Their challenge was that existing methods for measuring patient quality of life relied too much on recall and failed to capture the day-to-day experience of sufferers, which limited their ability to segment and support different types of patients and healthcare providers effectively.

Evidation addressed this by rapidly recruiting participants for a decentralized observational study. They collected permissioned data, including long-term wearable device metrics and electronic patient-reported outcomes, to provide an objective view of how the condition impacted daily life. The results revealed key drivers for prescriptions, gaps in patient support, and differences in sleep quality between segments. This provided the pharmaceutical company with actionable insights to improve marketing strategy, patient support, and scientific communication.